Northern Exposure PR

We are the leading public relations company serving the life science, pharmaceutical and technology industries.

Northern Exposure is the leading public relations company serving the life science, pharmaceutical and technology industries.

Twenty years experience maximising clients’ media exposure and advising on subjects from press handling, marketing strategy and reputation management

Northern Exposure Public Relations  is uniquely skilled in assisting clients in all public relations requirements

Meet Our Team

hac

Richard Kerns

Richard Kerns

Managing Director

Richard has twenty five years’ experience working with life science companies and organisations around the globe, both independently and within larger agencies.

Edward Dutton

Edward Dutton

Vice President

Ed has over fifteen years experience of working within the pharmaceutical industry, both as a laboratory chemist and in sales and marketing roles within contract research organisations, contract manufacturers and technology based companies.

Sarah Houlton

Sarah Houlton

Technical Consultant in Residence

Sarah has a degree and PhD in chemistry from Imperial College London, and worked as a drug discovery chemist in the pharmaceutical industry. As a science journalist, she has been writing about the pharmaceutical, biotech and chemical industries for more than twenty years.

Our Services

NEPR can assist clients in numerous manners, either on a retained agency basis or through project work around events. Activities include:

Planning & research, web content creation, media relations, technical articles, thought leadership articles, trade show and event management and support, social media, product launches, crisis management & more. 

Contact us today to find out how we can assist you

Our Clients

Client News

10/09/2018 IDEXX Pseudalert Test Accepted as Global ISO Standard

20/11/2018 Cambrex to Acquire Avista Pharma Solutions

03/12/2018 Catalent Invests $14 Million to Expand Biologics Packaging Capabilities Following Twentieth Commercial Drug Approval at Bloomington, Indiana Site

02/01/2019 Cambrex Completes Acquisition of Avista Pharma Solutions

04/01/2019 Catalent Invests $200 Million to Expand Biologics Capacity and Capabilities

12/02/2019 SGS to Conduct its First Malaria Human Challenge Trial in Belgium

13/02/2019 Catalent Names Alessandro Maselli President and Chief Operating Officer

18/02/2019 Catalent Receives P&G External Business Partner of the Year Award

21/02/2019 Catalent Appoints Kay Schmidt to Executive Leadership Team to Lead New Technical Operations Organization

07/03/2019 Catalent Invests Over $27 Million to Commercialize Zydis® Ultra, a Next Generation Oral Disintegrating Tablet

12/03/2019 Successful Phase 2 Clinical Trial Results with Novel Influenza Vaccine Validate SGS’s H3N2 Challenge Agent (A/Belgium)

14/03/2019 Cambrex Completes Expansion and Manufacturing Capability Upgrades in Milan

21/03/2019 Catalent Signs CEO Action for Diversity and Inclusion Pledge

01/04/2019 Triphase Accelerator Initiates Phase 1 Clinical Trial of TRPH-222 in B-cell Lymphoma

04/04/2019 Catalent Expands OptiMelt® Hot Melt Extrusion Capabilities at Somerset Drug Development Center of Excellence

10/04/2019 Cambrex Completes Highly Potent API Manufacturing Facility at Charles City, IA

11/04/2019 Catalent Celebrates Opening of Second Shanghai Facility to Optimize Global and Local Clinical Supply Solutions for China

15/04/2019 Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion

23/04/2019 Cambrex Completes New Quality Control Laboratory for Generic API Development in Milan

23/04/2019 Catalent Invests $14 Million at its Eberbach, Germany Softgel Facility

Upcoming Events

NEPR will be attending the following events:

CPhI North America

April 30–May 2, 2019

Chicago, IL

Healthcare Estates

October 8 – 9, 2019

Manchester, UK

CPhI Worldwide

November 5 – 7, 2019

Frankfurt, Germany

IDEXX Water UK are braving the heat this weekend to cycle the 60 miles from London to Cambridge for @AmnestyUK Good… https://t.co/3jFgsGfqNQ
about 10 months ago | @NrthnExposurePR